DIVY

WELLINGTON: Lunit said it has received the first-phase approval from the New Zealand ... read more

SYDNEY: David Di Pilla’s already had a big 12 -months. The former UBS ... read more

MELBOURNE: Dimerix will rapidly expand the phase three clinical trial of its flagship ... read more

MELBOURNE: Shares in Australian biopharmaceutical company Mesoblast jumped as much as 25 per ... read more